{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:46:12Z","timestamp":1786995972999,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.prp.2024.155729","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T05:12:25Z","timestamp":1731993145000},"page":"155729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Direct and indirect modulation of STAT3\/CSE\/H2S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486\u20135p and miR-30a-5p"],"prefix":"10.1016","volume":"265","author":[{"given":"Rana A.","family":"Youness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Khater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"El-Khouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Nafea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Manie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danira","family":"Habashy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Z.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.prp.2024.155729_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21063","article-title":"Dual targeting of H(2)S synthesizing enzymes; cystathionine \u03b2-synthase and cystathionine \u03b3-lyase by miR-939-5p effectively curbs triple negative breast cancer","volume":"9","author":"Nafea","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.prp.2024.155729_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2024.155729_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-18144-8_12","article-title":"Hydrogen sulfide and cancer","volume":"230","author":"Hellmich","year":"2015","journal-title":"Handb. Exp. Pharm."},{"issue":"5","key":"10.1016\/j.prp.2024.155729_bib4","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3892\/or.2017.5513","article-title":"Role of the cystathionine beta-synthase\/H2S system in liver cancer cells and the inhibitory effect of quinolone-indolone conjugate QIC2 on the system","volume":"37","author":"Jia","year":"2017","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.prp.2024.155729_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2024.155729_bib7","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1002\/jcp.30234","article-title":"LncRNA HEIH\/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production","volume":"236","author":"Nafea","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ncrna.2020.01.001","article-title":"MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions","volume":"5","author":"ElKhouly","year":"2020","journal-title":"Noncoding RNA Res."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11010-022-04378-4","article-title":"MALAT-1\/p53\/miR-155\/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer","volume":"477","author":"Abdel-Latif","year":"2022","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.prp.2024.155729_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.847543","article-title":"Expression of GPR68, an acid-sensing orphan G protein-coupled receptor, in breast cancer","volume":"12","author":"Elemam","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2024.155729_bib11","article-title":"Let-7a\/cMyc\/CCAT1\/miR-17-5p circuit resensitizes atezolizumab resistance in triple negative breast cancer through modulating PD-L1","volume":"248","author":"Selem","year":"2023","journal-title":"Pathol. Res. Pr."},{"key":"10.1016\/j.prp.2024.155729_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jare.2020.07.006","article-title":"Targeting hydrogen sulphide signaling in breast cancer","volume":"27","author":"Youness","year":"2021","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib13","first-page":"867","article-title":"Curcumin analoggue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas","volume":"35","author":"Hutzen","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semcdb.2008.06.005","article-title":"The function of Stat3 in tumor cells and their microenvironment","volume":"19","author":"Groner","year":"2008","journal-title":"Semin Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.prp.2024.155729_bib15","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-09-2468","article-title":"Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2024.155729_bib16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1349-7006.2011.01932.x","article-title":"Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells","volume":"102","author":"Liu","year":"2011","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.prp.2024.155729_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155729_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2018.07.004","article-title":"A novel role of sONE\/NOS3\/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression","volume":"80","author":"Youness","year":"2018","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10911-022-09511-z","article-title":"Decoding insulin-like growth factor signaling pathway from a non-coding RNAs perspective: a step towards precision oncology in breast cancer","volume":"27","author":"ZeinElAbdeen","year":"2022","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"39","key":"10.1016\/j.prp.2024.155729_bib20","doi-asserted-by":"crossref","first-page":"65677","DOI":"10.18632\/oncotarget.20057","article-title":"Cystathionine- gamma-lyase promotes process of breast cancer in association with STAT3 signaling pathway","volume":"8","author":"You","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1023720928680","article-title":"The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: biology and therapeutic relevance","volume":"22","author":"Gross","year":"2003","journal-title":"Cancer Metastas Rev."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib22","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3892\/ol.2016.4914","article-title":"MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc","volume":"12","author":"Youness","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155729_bib23","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2023.26","article-title":"Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology","volume":"26","author":"Elemam","year":"2024","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib24","article-title":"Role of hydrogen sulfide in oncological and non-oncological disorders and its regulation by non-coding RNAs: a comprehensive review","volume":"10","author":"Youness","year":"2024","journal-title":"Noncoding RNA"},{"issue":"21","key":"10.1016\/j.prp.2024.155729_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215244","article-title":"Molecular engines, therapeutic targets, and challenges in pediatric brain tumors: a special emphasis on hydrogen sulfide and RNA-based nano-delivery","volume":"14","author":"Fahmy","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ncrna.2022.09.011","article-title":"Circular RNAs: New layer of complexity evading breast cancer heterogeneity","volume":"8","author":"Dawoud","year":"2023","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.prp.2024.155729_bib27","article-title":"Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19\/iNOS\/PD-L1 axis","volume":"44","author":"Soliman","year":"2023","journal-title":"Photo Photo Ther."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ncrna.2021.11.001","article-title":"What is beyond LncRNAs in breast cancer: a special focus on colon cancer-associated Transcript-1 (CCAT-1)","volume":"6","author":"Selem","year":"2021","journal-title":"Noncoding RNA Res."},{"issue":"18","key":"10.1016\/j.prp.2024.155729_bib29","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/emboj.2010.199","article-title":"A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression","volume":"29","author":"Bernard","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.prp.2024.155729_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101653","article-title":"MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer","volume":"31","author":"Mekky","year":"2023","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11010-022-04378-4","article-title":"MALAT-1\/p53\/miR-155\/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer","volume":"477","author":"Abdel-Latif","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.prp.2024.155729_bib32","first-page":"3186","article-title":"LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever","volume":"10","author":"Li","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.prp.2024.155729_bib33","first-page":"2683","article-title":"MALAT1 promotes angiogenesis of breast cancer","volume":"40","author":"Huang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2024.155729_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtn.2018.07.014","article-title":"Expression analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in breast cancer tissues from young women and women over 45 years of age","volume":"12","author":"Arshi","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.prp.2024.155729_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cellsig.2018.08.004","article-title":"The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer","volume":"51","author":"Zhao","year":"2018","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ncrna.2019.01.003","article-title":"Long noncoding RNAs: functional regulatory players in breast cancer","volume":"4","author":"Youness","year":"2019","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib37","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aca85d","article-title":"Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer","volume":"18","author":"Ramzy","year":"2022","journal-title":"Biomed. Mater."},{"issue":"3","key":"10.1016\/j.prp.2024.155729_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1871520621666210419093652","article-title":"Hindering the synchronization between miR-486-5p and H19 lncRNA by hesperetin halts breast cancer aggressiveness through tuning ICAM-1","volume":"22","author":"Abdallah","year":"2022","journal-title":"Anticancer Agents Med. Chem."},{"issue":"3-4","key":"10.1016\/j.prp.2024.155729_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/08977194.2016.1200571","article-title":"Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression","volume":"34","author":"Youness","year":"2016","journal-title":"Growth Factors"},{"issue":"11","key":"10.1016\/j.prp.2024.155729_bib40","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.1007\/s13277-014-2412-0","article-title":"MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.prp.2024.155729_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13402-014-0176-6","article-title":"Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status","volume":"37","author":"Rask","year":"2014","journal-title":"Cell Oncol. (Dordr. )"},{"issue":"5","key":"10.1016\/j.prp.2024.155729_bib42","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1007\/s13277-015-4456-1","article-title":"Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH\/PTEN\/AKT pathway","volume":"37","author":"Li","year":"2016","journal-title":"Tumor Biol."},{"issue":"24","key":"10.1016\/j.prp.2024.155729_bib43","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1038\/onc.2013.286","article-title":"MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.prp.2024.155729_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115622","article-title":"UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt\/beta-catenin pathway","volume":"10","author":"Wen","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.prp.2024.155729_bib45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.03.069","article-title":"MiR-30a-5p\/UBE3C axis regulates breast cancer cell proliferation and migration","volume":"516","author":"Xiong","year":"2019","journal-title":"Biochem. Biophys. Res Commun."},{"issue":"4","key":"10.1016\/j.prp.2024.155729_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042070","article-title":"Hijacking 5-fluorouracil chemoresistance in triple negative breast cancer via microRNAs-loaded chitosan nanoparticles","volume":"25","author":"Fahmy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2024.155729_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/BD-200454","article-title":"miR-744\/eNOS\/NO axis: a novel target to halt triple negative breast cancer progression","volume":"40","author":"El Kilany","year":"2021","journal-title":"Breast Dis."},{"issue":"5","key":"10.1016\/j.prp.2024.155729_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/2211536609666201209152949","article-title":"miRNA-506-3p Directly Regulates rs10754339 (A\/G) in the immune checkpoint protein B7-H4 in breast cancer","volume":"9","author":"El Din","year":"2020","journal-title":"Microrna"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12935-024-03317-1","article-title":"Pan-inhibition of the three H(2)S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer.","volume":"24","author":"Dawoud","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"18","key":"10.1016\/j.prp.2024.155729_bib50","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1080\/14786419.2019.1686372","article-title":"An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR- 20a-MICA\/B axis","volume":"35","author":"Awad","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"11","key":"10.1016\/j.prp.2024.155729_bib51","doi-asserted-by":"crossref","first-page":"20286","DOI":"10.1002\/jcp.28629","article-title":"The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a","volume":"234","author":"Youness","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.prp.2024.155729_bib52","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00705-019-04232-x","article-title":"Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models","volume":"164","author":"Mekky","year":"2019","journal-title":"Arch. Virol."},{"key":"10.1016\/j.prp.2024.155729_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101961","article-title":"A novel epigenetic strategy to concurrently block immune checkpoints PD-1\/PD-L1 and CD155\/TIGIT in Hepatocellular Carcinoma","volume":"45","author":"Assal","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-018-0606-4","article-title":"MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches","volume":"11","author":"Amodio","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155729_bib55","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s13277-014-2631-4","article-title":"MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K\/Akt pathway","volume":"36","author":"Dong","year":"2015","journal-title":"Tumour Biol."},{"issue":"2-3","key":"10.1016\/j.prp.2024.155729_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/08977194.2017.1354859","article-title":"MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients","volume":"35","author":"Rahmoon","year":"2017","journal-title":"Growth Factors"},{"issue":"1","key":"10.1016\/j.prp.2024.155729_bib57","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41598-017-05457-z","article-title":"Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"37","key":"10.1016\/j.prp.2024.155729_bib58","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.1307107110","article-title":"Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer","volume":"110","author":"Peng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400640X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400640X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:12:12Z","timestamp":1759259532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382400640X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":58,"alternative-id":["S034403382400640X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155729","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct and indirect modulation of STAT3\/CSE\/H2S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486\u20135p and miR-30a-5p","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155729"}}